VJOncology is committed to improving our service to you

BOPA/ISOPP 2019 | Biosimilars in pharmacy practice: trastuzumab, rituximab and beyond

VJOncology is committed to improving our service to you

Rob Duncombe

Biosimilars can bring many benefits; here, Rob Duncombe, of the Christie NHS Foundation Trust, Manchester, UK, discusses the biosimilars currently being used in cancer treatment, and the key role of pharmacists in their implementation and usage. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

Share this video  
10th October 2019

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter